TransCode publishes preclinical data on glioblastoma treatment

Go back to TransCode publishes preclinical data on glioblastoma treatment
(NASDAQ: RNAZ) Delayed: 8.56 --0 (-0%)
Previous Close $8.56    52 Week High
Open $8.56    52 Week Low
Day High $8.56    P/E N/A 
Day Low $8.56    EPS
Volume 264